Browsing by Subject "Designer drugs"
Now showing items 1-2 of 2
-
The prevalence of novel psychoactive substances (NPS) use in non-clinical populations: a systematic review protocol
( BioMed Central , 2016 , Article)Background Novel psychoactive substances (NPS) are new narcotic or psychotropic drugs that are not controlled by the United Nations drug convention that may pose a serious public health threat due to their wide availability ... -
The synthetic cannabinoids menace: a review of health risks and toxicity
( Springer Nature , 2024 , Article)Synthetic cannabinoids (SCs) are chemically classified as psychoactive substances that target the endocannabinoid system in many body organs. SCs can initiate pathophysiological changes in many tissues which can be severe ...